Growth in reconstructive Enovis operates in the medical technology space with a focus on musculoskeletal devices and reconstructive solutions, suggesting opportunities to cross-sell adjacent implants, supports, and recovery products to surgeons and hospitals expanding their spine, joint replacement, and limb restoration programs.

Innovation and new products Recent product launches such as Spinamic Hybrid Scoliosis Brace indicate ongoing R&D and regulatory approval activity, signaling a pipeline of wearables and adjustable devices that can be paired with digital health and remote monitoring offerings to boost adoption and outcomes.

Global scale assets With a large, multinational footprint and brands like DonJoy, Aircast, and MotionMD, there is leverage to upsell integrated solutions across continents, pairing devices with digital platforms and service contracts to streamline procurement and clinical workflows.

Financial momentum Strong Q1 2026 performance, share gains in reconstructive surgery, and strategic investments point to growing demand and budget availability in hospital networks, providing near-term opportunities for expanded product lines and performance-based procurement deals.

Strategic partnerships Active collaboration with clinicians and health systems, plus acquisitions focus, creates entry points for co-development, white-labeling, and bundled offerings that combine hardware, software (e.g., MotionMD), and services to differentiate Enovis in competitive markets.